$3.13
0.123.82%
Last update: 3:14 PM
15 minutes delayed
Vistagen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vistagen Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.35 | $-0.40 | 12.5 % |
Mar 2024 | 2024-06-11 | $-0.25 | $-0.37 | 32.4 % |
Dec 2023 | 2024-02-13 | $-0.22 | $-0.30 | 26.7 % |
Sep 2023 | 2023-11-09 | $-0.66 | $-0.68 | 2.94 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $84.00K | $300.00K | -72.0 % |
Mar 2024 | 2024-06-11 | $197.30K | $410.00K | -51.9 % |
Dec 2023 | 2024-02-13 | $411.40K | $540.00K | -23.8 % |
Sep 2023 | 2023-11-09 | $277.70K | $180.00K | 54.3 % |
Vistagen Therapeutics (VTGN) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q1.
The Actual EPS was $-0.35, which beat the estimate of $-0.40.
The Actual Revenue was $84K, which missed the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.